Ignite Creation Date:
2025-12-25 @ 1:12 AM
Ignite Modification Date:
2026-04-09 @ 10:48 AM
Study NCT ID:
NCT00542893
Status:
COMPLETED
Last Update Posted:
2012-03-13
First Post:
2007-10-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I, Randomized, Open-label, Cross-over, Pharmacokinetic Study of Genasense With and Without Dacarbazine
Sponsor:
Genta Incorporated
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
GPK105
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None